CA209-650
17 Mar 2017
Checkmate 650
NCT02985957
Study of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer
Bristal-Myers Squibb
Cancer Type | Prostate |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | 18+ years |
Sex | Male |
Tumour Stream | Prostate cancer |
Cancer Stage | Metastatic or Widespread |
Anticipated Start Date | 2017-03-17 |
Anticipated End Date | 2022-05-30 |
Hospital | Lyell McEwin Hospital |
---|---|
Clinical Trial Coordinator | Andy Phay |
andy.phay@sa.gov.au | |
Phone | 08 8282 0833 |
Principal Investigator | Dr Christopher Hocking |
Recruitment Status | Recruiting |